Tags

Type your tag names separated by a space and hit enter

Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders.
J Biol Regul Homeost Agents 2019 Mar-Apr,; 33(2):609-615JB

Abstract

Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broser® is an oral nutraceutical currently containing bromelain 100 mg, escin 30 mg, and selenium 42.5 mcg. It could exert a safe and effective anti-inflammatory activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients.

Authors+Show Affiliations

ENT Department, University of Palermo, Palermo, ItalyOtolaryngology Unit, Department of Basic Medical Science, Neuroscience and Sensory Organs, University of Bari Aldo Moro, Bari, ItalyENT Department, University of Catania, Catania, ItalyCenter of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), ItalyAllergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy
Italian Study Group on Inflammatory Otorhinolaryngological Disorders. Aielli Federica, Albanese Gianluca, Allosso Giuseppe, Amadori Maurizio, Antoniacomi Giovanni, Asprea Francesco, Auletta Pasquale, Azzaro Raffaele, Balduzzi Attilio, Bellini Vito, Benedetto Domenico, Berardi Carlo, Bernardi Rosanna, Bianchi Alessandro, Bordonaro Carla, Brindisi Annamaria, Buccolieri Marcello, Bulzomì Antonio Giovanni, Caligo Giacomo, Cantaffa Antonio, Carboni Sebastiano, Cascio Felice, Cassano Michele, Castagna Giovanni, Castellani Francesca, Chillura Mario, Colombo Giovanni, Corbetta Marco, Cordier Aldo, Costanzo Marcello, Cupido Francesco, Cupido Gianfranco, Danza Carlo, De Luca Carlo, Di Maria Domenico, Falcetti Saverio, Falciglia Roberto, Ferraro Guglielmo, Forte Sebastiano, Franco Teresa, Franzetti Andrea, Frisina Antonio, Gambardella Giuseppe, Gambardella Tullio, Iannello Franco, Ierace Michelangelo, Ingria Federico, La Mantia Ignazio, La Paglia Alessandro, Leone Mirko, Lingua Cristiano, Lovotti Paolo, Machetta Giacomo, Maddalena Gianluca, Maffezzoni Enrico, Mangiatordi Francesco Gerardo, Maniscalco Francesco, Melis Andrea, Mercurio Antonio, Milone Vincenzo, Mirra Nicola, Montanaro Salvatore Carmine, Moro Davide, Muià Fernando, Mussella Tommaso, Nacci Andrea, Padovani Davide, Panetti Maria Luisa, Paoletti Matteo, Piccolo Marcello, Pizzolante Maurizio Cosimo, Principi Pietro, Sari Marianna, Scarpa Alfonso, Serraino Eugenio Maurizio, Stabile Carlo, Tomacelli Giovanni, Tombolini Alberto, Trichini Antonio Fabio, Vergari Alessandro, Zaraca Giorgio
Italian Study Group of inflammatory otorhinolaryngological disorders

Pub Type(s)

Letter
Multicenter Study

Language

eng

PubMed ID

30891997

Citation

Cupido, G F., et al. "Broser® (bromelain, Escin and Selenium), Oral Nutraceutical, Monotherapy in Patients With Inflammatory Otorhinolaryngological Disorders." Journal of Biological Regulators and Homeostatic Agents, vol. 33, no. 2, 2019, pp. 609-615.
Cupido GF, Gelardi M, La Mantia I, et al. Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders. J Biol Regul Homeost Agents. 2019;33(2):609-615.
Cupido, G. F., Gelardi, M., La Mantia, I., Aragona, S. E., & Ciprandi, G. (2019). Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders. Journal of Biological Regulators and Homeostatic Agents, 33(2), pp. 609-615.
Cupido GF, et al. Broser® (bromelain, Escin and Selenium), Oral Nutraceutical, Monotherapy in Patients With Inflammatory Otorhinolaryngological Disorders. J Biol Regul Homeost Agents. 2019;33(2):609-615. PubMed PMID: 30891997.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders. AU - Cupido,G F, AU - Gelardi,M, AU - La Mantia,I, AU - Aragona,S E, AU - Ciprandi,G, AU - ,, PY - 2019/3/21/entrez PY - 2019/3/21/pubmed PY - 2019/6/19/medline KW - selenium KW - inflammation KW - otorhinolaryngology KW - bromelain KW - escin SP - 609 EP - 615 JF - Journal of biological regulators and homeostatic agents JO - J. Biol. Regul. Homeost. Agents VL - 33 IS - 2 N2 - Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broser® is an oral nutraceutical currently containing bromelain 100 mg, escin 30 mg, and selenium 42.5 mcg. It could exert a safe and effective anti-inflammatory activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients. SN - 0393-974X UR - https://www.unboundmedicine.com/medline/citation/30891997/Broser®_(bromelain,_escin_and_selenium),_oral_nutraceutical,_monotherapy_in_patients_with_inflammatory_otorhinolaryngological_disorders DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows